This is accurate. A phase 3 ready blue sky indication is worth a lot of money. When negotiating the terms, there are several dozen possibilities based on share price. It is actually a little more complicated at these levels due to “appearance” to opposite stakeholders. It will get done because again....it’s a race to the finish line.
Has anyone found out if this trial can be much quicker than the other IV trials? Since it’s swish and spit? Less regulation or roadblocks? I understand it’s same time frames with patients, but due to oral mouthwash type drug, are there any positives?
News 
Market Data 
Discover 
